Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Log in

Welcome to Biotechgate, your source for life science information.

Please use your username and password to log in to your account.

 

No account yet?

Try Biotechgate now - learn about subscription plans and pricing!

Latest News

HUTCHMED Highlights Fruquintinib Clinical Data to be Presented at the 2022 ASCO Gastrointestinal Cancers Symposium
19 Jan 2022
(GlobenewsWire)
FIRST SUBJECT ENROLLED IN PHASE II/III STUDY OF EISAI'S ANTI-MTBR TAU ANTIBODY E2814 FOR DOMINANTLY INHERITED ALZHEIMER'S DISEASE (DIAD), CONDUCTED BY DIAN-TU
19 Jan 2022
(PR Newswire Association LLC.)
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Ankylosing Spondylitis
19 Jan 2022
(PR Newswire Association LLC.)

Upcoming conferences

See Events »
Add an Event »

Latest updates

18 January 2022
Updates within the latest 30 days:
to the top ↑